P

Inventor

YIN ZHIWEI

US45 patents
⚠️ This page may combine multiple inventors who share the name “YIN ZHIWEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

26 patents
US7354924B2Apr 8, 2008

Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

BRISTOL MYERS SQUIBB CO106 citations99
US7807676B2Oct 5, 2010

Diketo-Piperazine and Piperidine derivatives as antiviral agents

BRISTOL MYERS SQUIBB CO17 citations92
US7807671B2Oct 5, 2010

Diketo-piperazine and piperidine derivatives as antiviral agents

BRISTOL MYERS SQUIBB CO29 citations92
US7662823B2Feb 16, 2010

Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives

BRISTOL MYERS SQUIBB CO17 citations92
US7501420B2Mar 10, 2009

Composition and antiviral of substituted azaindoleoxoacetic piperazine derivatives

BRISTOL MYERS SQUIBB CO21 citations92
US7348337B2Mar 25, 2008

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

BRISTOL MYERS SQUIBB CO37 citations92
US7396830B2Jul 8, 2008

Piperazine amidines as antiviral agents

BRISTOL MYERS SQUIBB CO16 citations84
US7960406B2Jun 14, 2011

Diketo substituted pyrrolo[2,3-c] pyridines

BRISTOL MYERS SQUIBB CO5 citations74
US10131645B2Nov 20, 2018

Benzofurans substituted with primary benzamide as HCV inhibitors

BRISTOL MYERS SQUIBB CO2 citations73
US10125111B2Nov 13, 2018

Benzofuran compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO3 citations73
US8916702B2Dec 23, 2014

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO4 citations73
US9156828B2Oct 13, 2015

Tricyclic amidine derivatives as HIV attachment inhibitors

BRISTOL MYERS SQUIBB CO3 citations63
US8987264B2Mar 24, 2015

1,3,5-triazine derivatives of spiro bicyclic oxalamide-compounds for treatment of hepatitis C

BRISTOL MYERS SQUIBB CO2 citations63
US7915283B2Mar 29, 2011

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

BRISTOL MYERS SQUIBB CO3 citations61
US6774134B2Aug 10, 2004

Heterocyclic substituted 2-methyl-benzimidazole antiviral agents

BRISTOL MYERS SQUIBB CO5 citations61
US10570108B2Feb 25, 2020

Substituted benzofuran compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO0 citations52
US10125137B2Nov 13, 2018

Benzofurans substituted with bicyclic secondary benzamide as HCV inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US9918988B2Mar 20, 2018

Ammonium derivatives for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO0 citations52
US9920036B2Mar 20, 2018

Cyanoamino (aza)benzofuran compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO1 citations52
US9745322B2Aug 29, 2017

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO0 citations52
US6844342B2Jan 18, 2005

Heterocyclic substituted 2-methyl-benzimidazole antiviral agents

BRISTOL MYERS SQUIBB CO0 citations50
US10087167B2Oct 2, 2018

Benzofurans substituted with secondary benzamide as HCV inhibitors

BRISTOL MYERS SQUIBB CO0 citations42
US9655902B2May 23, 2017

Guanidine derivatives for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO0 citations42
US9624245B2Apr 18, 2017

Macrocyclic compounds as HCV entry inhibitors

BRISTOL MYERS SQUIBB CO0 citations42
US9249152B2Feb 2, 2016

Cyano containing azabenzofuran compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO0 citations42
US8987265B2Mar 24, 2015

Substituted 1,3,5-triazine derivatives of fused bicyclic oxalamide compounds for treatment of Hepatitis C

BRISTOL MYERS SQUIBB CO0 citations42

WANG TAO

4 patents

VIIV HEALTHCARE UK NO 5 LTD

4 patents

VIIV HEALTHCARE UK (NO 5) LTD

3 patents

Outdoor Wireless Networks LLC

2 patents

GLOBAL TECH INC

2 patents

BRISTOL MYERS SQIBB COMPANY

1 patent

BRISTOL MEYERS SQUIBB CO

1 patent

CELGENE CORP

1 patent

UNIV XUZHOU TECHNOLOGY

1 patent